What is Nova Surgicare?
Nova Surgicare operates as a premier medical facility specializing in facial cosmetic surgery, oral and maxillofacial procedures, and advanced non-surgical aesthetic solutions. Based in the greater Washington, D.C. area, the practice distinguishes itself through a commitment to high-precision care, offering a comprehensive suite of services ranging from rhinoplasty and blepharoplasty to complex dental implantology. Under the leadership of double board-certified surgeon Dr. Daria Hamrah, the clinic integrates clinical expertise with a patient-centric philosophy, catering to individuals seeking tailored cosmetic outcomes. The firm occupies a critical niche in the elective healthcare sector, balancing medical necessity with aesthetic refinement to maintain a high standard of patient satisfaction and clinical safety.
How much funding has Nova Surgicare raised?
Nova Surgicare has raised a total of $120K across 1 funding round:
Debt
$120K
Debt (2021): $120K with participation from PPP
Key Investors in Nova Surgicare
PPP
Public-Private Partnership
What's next for Nova Surgicare?
With the successful closure of this late-stage funding round, Nova Surgicare is poised to accelerate its strategic initiatives. The organization is expected to focus on scaling its operational capacity, potentially through the acquisition of cutting-edge surgical technology and the expansion of its facility footprint to accommodate increasing patient demand. Furthermore, the capital will likely support the refinement of its non-surgical treatment portfolio, allowing the practice to capture a larger share of the growing aesthetic medicine market. By maintaining its focus on high-quality, board-certified surgical outcomes, Nova Surgicare is strategically aligned to sustain its competitive advantage and drive long-term value in the specialized healthcare services industry.
See full Nova Surgicare company page